InvestorsHub Logo
Followers 7
Posts 190
Boards Moderated 0
Alias Born 10/03/2013

Re: lightrock post# 39328

Tuesday, 06/29/2021 6:18:03 PM

Tuesday, June 29, 2021 6:18:03 PM

Post# of 43784
I've been wondering - is it possible that the likelihood of lack of efficacy of MK for the patient subset receiving chemo was not foreseen simply because it couldn't have been known? Immunotherapy is still a new field, and the trial was designed a decade ago (or more). A lot has happened since then. Wasn't it just last year, or the year before, that the trend for the benefit of immunotherapies to increase (statistically) over time was being recognized for the first time?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News